Bonstein Sara's Form 4 filing
INSMED Inc (INSM) · filed Jan 12, 2023
- Accession no.
- 0001628280-23-000958
- Filed
- Jan 12, 2023
- Trade date
- Jan 10, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $51.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bonstein SaraCIK 0001604019 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 10, 2023 | Common Stock | SSaleDisposed | −2,857 | $18.12F2 | −$51,768.84 | 66,031 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This is the weighted average sales price representing 2,857 shares sold at prices ranging from $18.03 to $18.19 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.